InsidersTradesSigma
Track the 瑞迈特 share price and the full directors' dealings record of the company, a listed equity based in China. Shares are quoted on the CN market, under the authority of SSE / SZSE (CSRC). Operating in the Health Care sector, 瑞迈特 has logged 5 insider filings. Market capitalisation: €5.9bn. The latest transaction was reported on 5 January 2026 (Sale). Among the most active insiders: 陈蓓. Every trade is free.
5
Insider Decl.
n/a
Thresholds
n/a
n/a
Buy Volume
€6m
5 ops.
Sell Volume
7Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 10,945 of 29,063 companies
57.7
score / 100
Value43
Quality73
FCF yld1.7%
Earn yld3.8%
EV/EBITDA20.6x
ROE6.6%
Gross mgn53%
Net mgn19%
Debt/EBITDA0.3x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 5 January 2026
Declarations5 total
5 of 5 declarations
Acerca de 瑞迈特
瑞迈特 es una empresa que opera en el sector de la salud y farmacéutico, cotizada en el mercado XSHE. Se centra en el desarrollo y la comercialización de productos farmacéuticos innovadores.